Fig. 6
From: Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma
The relationships between CR risk levels and TIM. A The differences in infiltration levels of 21 immune cells between high- and low-CR risk levels. B The differences in activities of 10 immune-related signaling pathways between different CR risk levels. C The differences in immune scores between different CR risk levels based on ESTIMATE method. D The difference of tumor purity between different CR risk levels. E The somatic mutation information of four CR signature genes based on cBioPortal database. NS, no statistical significance; *P < 0.05, **P < 0.01, ***P < 0.001